Gestational Diabetes Mellitus Diagnosis and Management at 30 Weeks Gestation

Diagnostic Approaches

The American Diabetes Association recommends performing a 75g oral glucose tolerance test with fasting, 1-hour, and 2-hour plasma glucose measurements to diagnose gestational diabetes mellitus (GDM) at 30 weeks gestation, with GDM diagnosed if any one of the following values is met or exceeded: fasting ≥92 mg/dL, 1-hour ≥180 mg/dL, or 2-hour ≥153 mg/dL 1, 2
Alternatively, a two-step approach can be used, starting with a 50g glucose load test, and if the 1-hour value is ≥140 mg/dL, proceeding to a 100g OGTT with measurements at fasting, 1-hour, 2-hour, and 3-hour, diagnosing GDM if two or more of the following Carpenter/Coustan criteria are met or exceeded: fasting ≥95 mg/dL, 1-hour ≥180 mg/dL, 2-hour ≥155 mg/dL, or 3-hour ≥140 mg/dL 2, 3

The standard screening window for GDM is 24-28 weeks gestation, as insulin resistance peaks during pregnancy and GDM typically manifests, with the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study demonstrating continuous graded associations between maternal glycemia and adverse outcomes 1, 3
Diagnosing GDM at 30 weeks gestation allows for approximately 8-10 weeks of glycemic management before delivery, which can reduce adverse outcomes 1

The American College of Obstetricians and Gynecologists notes that both one-step and two-step approaches are acceptable for GDM diagnosis, with regional preferences varying, and recent evidence suggesting both approaches can reduce adverse outcomes when GDM is treated 1, 2
The American Diabetes Association recommends against using HbA1c for GDM screening at this stage, as it does not perform as well as glucose tolerance testing for GDM diagnosis, and if testing reveals fasting plasma glucose ≥126 mg/dL or random glucose ≥200 mg/dL with symptoms, this indicates overt diabetes and requires immediate treatment 1, 2, 5

The American College of Obstetricians and Gynecologists recommends that all women diagnosed with GDM should be screened for persistent diabetes at 4-12 weeks postpartum using a 75g OGTT with non-pregnancy diagnostic criteria, and lifelong screening for diabetes or prediabetes should continue at least every 3 years 1, 2, 5, 6